3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Multiple Myeloma
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Myelodysplastic Syndromes
13
Neuroblastoma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
4
Hodgkin Disease
4
Hematologic Neoplasms
4
Neoplasm, Residual
3
Myeloproliferative Disorders
3
Lymphoma
3
Anemia, Refractory, with Excess of Blasts
3
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Biphenotypic, Acute
2
Graft vs Host Disease
2
Ganglioneuroblastoma
2
Burkitt Lymphoma
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Venentoclax
1
Smoldering Multiple Myeloma
1
Sarcoma, Ewing
1
Rhabdomyosarcoma
1
Recurrence
1
Rectal Neoplasms
1
Preleukemia
1
Precancerous Conditions
1
Plasmablastic Lymphoma
1
Osteosarcoma
1
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
LY3023414
2
talazoparib
1
olaparib
1
irinotecan sucrosofate
1
amino-acid, glucose, and electrolyte solution
1
Vemurafenib
1
Temozolomide
1
Pharmacogenomic Variants
1
Liquid Biopsy
1
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors, Primitive, Peripheral
×
Melphalan
×
90 days
×
Clear all
No trials found.